TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

GlaxoSmithKline Inks Medical 'Bioelectronics' Partnership With Alphabet
Play
INVESTING

GlaxoSmithKline and Sanofi Re-Start COVID Vaccine Trials

  • By Martin Baccardax
  • Feb 22, 2021 6:52 AM EST
Vir Biotechnology Lead
INVESTING

Vir Biotech Jumps on New Drug Development Deal With GSK

  • By Dan Weil
  • Feb 17, 2021 10:20 AM EST
PRESS RELEASES

TUMS Expands Portfolio To Meet Consumer Demands For Naturally-Sourced Products

  • By PR Newswire
  • Feb 16, 2021 10:01 AM EST
27 unitedhealth group IgorGolovniov : Shutterstock.
INVESTING

UnitedHealth Retiring CEO to Get 2 Years of Salary, Bonus

  • By Rob Lenihan
  • Feb 9, 2021 1:47 PM EST
27 unitedhealth group IgorGolovniov : Shutterstock.
INVESTING

UnitedHealth Elevates President Andrew Witty to CEO

  • By Dan Weil
  • Feb 4, 2021 2:13 PM EST
The government has already secured millions of doses of the Pfizer-BioNtech Covid-19 vaccine. Photo: AFP
INVESTING

CureVac Shares Leap On COVID Vaccine Pact With GlaxoSmithKline

  • By Martin Baccardax
  • Feb 3, 2021 10:03 AM EST
PRESS RELEASES

TUMS® Kicks Off $55,000 #TUMSBingoSweepstakes For The BIG GAME

  • By PR Newswire
  • Feb 1, 2021 10:00 AM EST
Sanofi Lead
INVESTING

Pfizer and BioNTech Get Help From Sanofi on Vaccine Production

  • By M. Corey Goldman
  • Jan 27, 2021 6:35 AM EST
PRESS RELEASES

Moderna Provides Business Update And Announces Three New Development Programs In Infectious Disease Vaccines

  • By Business Wire
  • Jan 11, 2021 7:20 AM EST
PRESS RELEASES

Eligo Inks Deal With GSK Potentially Worth Up To $224M

  • By PR Newswire
  • Jan 11, 2021 7:00 AM EST
Glaxo, IP and PetMed Poised to Go Higher
INVESTING

Eidos Reportedly Received $4.6 Billion Takeover Bid From Glaxo

  • By Dan Weil
  • Dec 14, 2020 9:10 AM EST
General Electric CEO Flannery Is Already Starting to Right the Ship, Jim Cramer Says
INVESTING

Morning Bell With Jim Cramer: Buy General Electric

  • By Fatma Khaled
  • Nov 23, 2020 8:40 AM EST
Getting Glaxo Back to Good Health
INVESTING

GlaxoSmithKline Joins COVID Vaccine Race With Phase 3 Trial

  • By Martin Baccardax
  • Nov 12, 2020 9:37 AM EST
Novavax Lead
INVESTING

Novavax Shares Off as Results Miss Estimates; New CFO Named

  • By Rob Lenihan
  • Nov 10, 2020 10:30 AM EST
Coronavirus vaccine Lead
Video

Diversification Key In Investing in Vaccine Race: Expert

  • Nov 2, 2020 10:35 AM EST
PRESS RELEASES

Robitussin Launches Their First-Ever Drug-Free Products For Cough Relief With A Cheerful Collaboration

  • By PR Newswire
  • Oct 28, 2020 8:48 AM EDT
Canon Continues to Lose Focus
INVESTING

Dunkin', Canon: 5 Top Stock Gainers for Monday

  • By Rob Lenihan
  • Oct 26, 2020 1:22 PM EDT
Coronavirus Masks Social Distance Lead
Video

Is PPE an Investing Opportunity Amid Race to Vaccine?

  • Oct 26, 2020 7:14 AM EDT
Chinese Prostate, Breast Cancer Drugs Maker Kintor's IPO More Than 500 Times Oversubscribed As Hong Kong Biotech Investment Fever Continues
INVESTING

Vir, GlaxoSmithKline Widen Trials of Covid Treatment Candidate

  • By Tony Owusu
  • Oct 6, 2020 12:41 PM EDT
Nvidia Lead
STOCKS

Nvidia Partners With GlaxoSmithKline to Use AI for Drug Development

  • By Rob Lenihan
  • Oct 5, 2020 11:22 AM EDT
PRESS RELEASES

ViiV Healthcare Presents A New Podcast About The Power Of Being Seen

  • By PR Newswire
  • Oct 1, 2020 9:05 AM EDT
PRESS RELEASES

FDA Approves Nucala As The First And Only Biologic Treatment For Hypereosinophilic Syndrome (HES)

  • By Business Wire
  • Sep 25, 2020 3:58 PM EDT
PRESS RELEASES

ViiV Healthcare Announces Availability Of CABENUVA And VOCABRIA In Canada

  • By PR Newswire
  • Sep 23, 2020 8:00 AM EDT
PRESS RELEASES

FDA Approves Trelegy Ellipta As The First Once-Daily Single Inhaler Triple Therapy For The Treatment Of Both Asthma And COPD In The US

  • By Business Wire
  • Sep 9, 2020 6:45 PM EDT
AstraZeneca Lead
INVESTING

AstraZeneca Shares Fall After COVID-19 Vaccine Study Placed on Hold

  • By Tom Bemis
  • Sep 8, 2020 7:05 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.